{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:56:41Z","timestamp":1784318201299,"version":"3.55.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Zigong Key Science and Technology Plan","award":["2023-NKY-02-04"],"award-info":[{"award-number":["2023-NKY-02-04"]}]},{"name":"the Zigong Key Science and Technology Plan","award":["2023-NKY-02-07"],"award-info":[{"award-number":["2023-NKY-02-07"]}]},{"name":"the Zigong Key Science and Technology Plan","award":["2023-NKY-03-03"],"award-info":[{"award-number":["2023-NKY-03-03"]}]},{"name":"the Collaborative Innovation Project of Zigong Medical Big Data and Artificial Intelligence Research Institute","award":["2024-YGY-02-04"],"award-info":[{"award-number":["2024-YGY-02-04"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background and objectives<\/jats:title>\n<jats:p>Patients with schizophrenia face an elevated risk of sarcopenic obesity (SO) due to antipsychotic-induced metabolic dysfunction, physical inactivity, and nutritional deficiencies. Although recent studies suggest an association between SO and cognitive decline, its specific impact on cognitive function in schizophrenia remains to be fully elucidated. This study aimed to evaluate the diagnostic concordance between the European Society for Clinical Nutrition and Metabolism\/European Association for the Study of Obesity (SO<jats:sub>ESPEN<\/jats:sub>) criteria and its modified version (SO<jats:sub>ESPEN-M<\/jats:sub>), and to examine their respective associations with cognitive function in inpatients with stable schizophrenia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In this cross-sectional analysis, 228 adults with stable schizophrenia were recruited. SO was diagnosed using two definitions: SO<jats:sub>ESPEN<\/jats:sub> (excess adiposity, low muscle mass-to-weight ratio, and reduced handgrip strength) and SO<jats:sub>ESPEN-M<\/jats:sub> (BMI-adjusted muscle mass threshold). Cognitive function was assessed using the Montreal Cognitive Assessment-Chinese version (MoCA-C). Multivariate linear regression models were employed to evaluate associations between SO and MoCA-C scores, adjusting for relevant demographic, clinical, and comorbidity-related variables.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>SO prevalence was 17.1% under both diagnostic criteria, with moderate inter-criteria agreement (\u03ba\u2009=\u20090.660). Sex-stratified analyses revealed divergent diagnostic trends: in males, SO prevalence increased from 15.9% (SO<jats:sub>ESPEN<\/jats:sub>) to 22.5% (SO<jats:sub>ESPEN-M<\/jats:sub>; \u03ba\u2009=\u20090.698); in females, prevalence decreased from 18.9% to 8.9% (\u03ba\u2009=\u20090.590). Across both criteria, SO groups demonstrated significantly lower MoCA-C scores (males: 16 vs 20, p\u2009=\u20090.045 for SO<jats:sub>ESPEN<\/jats:sub>; 13 vs 21, p\u2009&lt;\u20090.001 for SO<jats:sub>ESPEN-M<\/jats:sub>; females: 11 vs 17, p\u2009=\u20090.009 for SO<jats:sub>ESPEN<\/jats:sub>; 10.5 vs 17, p\u2009=\u20090.036 for SO<jats:sub>ESPEN-M<\/jats:sub>). Multivariate analysis confirmed that SO<jats:sub>ESPEN-M<\/jats:sub>-defined SO was independently associated with lower MoCA-C scores in males (\u03b2\u2009= \u22122.71, 95% CI: \u22125.08 to \u22120.33, p\u2009=\u20090.027).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our results demonstrate that SO defined by SO<jats:sub>ESPEN-M<\/jats:sub> criteria is significantly associated with cognitive impairment in male inpatients with stable schizophrenia.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0330453","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T17:24:46Z","timestamp":1755537886000},"page":"e0330453","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between sarcopenic obesity and cognitive functionality among inpatients with stable schizophrenia"],"prefix":"10.1371","volume":"20","author":[{"given":"Yan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5320-0274","authenticated-orcid":true,"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youguo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"12","key":"pone.0330453.ref001","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"M Solmi","year":"2023","journal-title":"Mol Psychiatry"},{"key":"pone.0330453.ref002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-pharmtox-051921-093250","article-title":"Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment","volume":"63","author":"DC Javitt","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"pone.0330453.ref003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.059","article-title":"Neural circuit dysfunction in schizophrenia: Insights from animal models","volume":"321","author":"T Sigurdsson","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"pone.0330453.ref004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41398-025-03259-w","article-title":"Narcolepsy as a potential risk factor for Schizophrenia","volume":"15","author":"R Eghtedarian","year":"2025","journal-title":"Transl Psychiatry"},{"issue":"4","key":"pone.0330453.ref005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5498\/wjp.v5.i4.352","article-title":"Conceptualization and treatment of negative symptoms in schizophrenia","volume":"5","author":"S Sarkar","year":"2015","journal-title":"World J Psychiatry"},{"issue":"8","key":"pone.0330453.ref006","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/molecules23082087","article-title":"Current Concepts and Treatments of Schizophrenia","volume":"23","author":"P St\u0119pnicki","year":"2018","journal-title":"Molecules"},{"key":"pone.0330453.ref007","doi-asserted-by":"crossref","first-page":"104257","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives","volume":"131","author":"FC Nucifora","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"3","key":"pone.0330453.ref008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"D Vancampfort","year":"2015","journal-title":"World Psychiatry"},{"issue":"7","key":"pone.0330453.ref009","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1016\/j.clnu.2021.06.009","article-title":"Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis","volume":"40","author":"Q Gao","year":"2021","journal-title":"Clin Nutr"},{"issue":"3","key":"pone.0330453.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00580","article-title":"Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer\u2019s disease","volume":"22","author":"M Mostafa","year":"2025","journal-title":"Neurotherapeutics"},{"key":"pone.0330453.ref011","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbi.2024.12.154","article-title":"Cognitive decline and neuroinflammation in a mouse model of obesity: An accelerating role of ageing","volume":"125","author":"M Rajput","year":"2025","journal-title":"Brain Behav Immun"},{"issue":"6","key":"pone.0330453.ref012","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf114","article-title":"The prognostic value of sarcopenia and sarcopenic obesity in patients with lung cancer receiving immunotherapy: a propensity score matching study","volume":"30","author":"W Wang","year":"2025","journal-title":"Oncologist"},{"issue":"12","key":"pone.0330453.ref013","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3390\/jcm14124191","article-title":"Association of Sarcopenia and Visceral Obesity with Clinical Outcomes Among Older Adults with Cardiovascular Disease: A Retrospective Cohort Study","volume":"14","author":"H-J Yoon","year":"2025","journal-title":"J Clin Med"},{"issue":"3","key":"pone.0330453.ref014","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s10620-025-08844-z","article-title":"Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)","volume":"70","author":"S-C Chien","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"1","key":"pone.0330453.ref015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12890-023-02702-2","article-title":"Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study","volume":"23","author":"Z Wang","year":"2023","journal-title":"BMC Pulm Med"},{"issue":"1","key":"pone.0330453.ref016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11657-025-01573-w","article-title":"Association of Sarcopenic Obesity and Osteoporosis in Postmenopausal Women: Risk Factors and Protective Effects of Hormonal Therapy and Nutritional Status","volume":"20","author":"O Chucherd","year":"2025","journal-title":"Arch Osteoporos"},{"key":"pone.0330453.ref017","doi-asserted-by":"crossref","first-page":"112544","DOI":"10.1016\/j.exger.2024.112544","article-title":"Sarcopenic obesity and osteoporosis: Research progress and hot spots","volume":"195","author":"S Fan","year":"2024","journal-title":"Exp Gerontol"},{"issue":"4","key":"pone.0330453.ref018","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"41","author":"LM Donini","year":"2022","journal-title":"Clin Nutr"},{"key":"pone.0330453.ref019","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.archger.2024.105557","article-title":"Sarcopenic obesity and falls in older adults: A validation study of ESPEN\/EASO criteria and modifications in Western China communities","volume":"127","author":"R Li","year":"2024","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"pone.0330453.ref020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"T Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"pone.0330453.ref021","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1017\/S0033291708004194","article-title":"Body composition in psychotic disorders: a general population survey","volume":"39","author":"SE Saarni","year":"2009","journal-title":"Psychol Med"},{"key":"pone.0330453.ref022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1265\/ehpm.25-00046","article-title":"Physical activity and risk of sarcopenia in 6500 community-dwelling Japanese people aged 40-74 years: an 8-year follow-up study","volume":"30","author":"S Wakana","year":"2025","journal-title":"Environ Health Prev Med"},{"issue":"5","key":"pone.0330453.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004592","article-title":"Sex-disaggregated data along the gendered health pathways: A review and analysis of global data on hypertension, diabetes, HIV, and AIDS","volume":"22","author":"A Feraldi","year":"2025","journal-title":"PLoS Med"},{"key":"pone.0330453.ref024","article-title":"Genetic Architecture and Analysis Practices of Circulating Metabolites in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program","author":"N Wang","year":"2025","journal-title":"bioRxiv"},{"issue":"12","key":"pone.0330453.ref025","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1038\/s41380-023-02154-4","article-title":"How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients","volume":"28","author":"G Fond","year":"2023","journal-title":"Mol Psychiatry"},{"key":"pone.0330453.ref026","doi-asserted-by":"crossref","first-page":"105557","DOI":"10.1016\/j.archger.2024.105557","article-title":"Sarcopenic obesity and falls in older adults: A validation study of ESPEN\/EASO criteria and modifications in Western China communities","volume":"127","author":"R Li","year":"2024","journal-title":"Arch Gerontol Geriatr"},{"key":"pone.0330453.ref027","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fnagi.2017.00400","article-title":"A Clinical Research Study of Cognitive Dysfunction and Affective Impairment after Isolated Brainstem Stroke","volume":"9","author":"X Fu","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"pone.0330453.ref028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/pcn.13779","article-title":"Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with moderate to severe cognitive impairment: A randomized controlled trial","volume":"79","author":"J Li","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"issue":"12","key":"pone.0330453.ref029","article-title":"Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment","volume":"64","author":"K-L Chen","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"pone.0330453.ref030","doi-asserted-by":"crossref","first-page":"115486","DOI":"10.1016\/j.psychres.2023.115486","article-title":"Youth screening depression: Validation of the Patient Health Questionnaire-9 (PHQ-9) in a representative sample of adolescents","volume":"328","author":"E Fonseca-Pedrero","year":"2023","journal-title":"Psychiatry Res"},{"key":"pone.0330453.ref031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jad.2022.10.047","article-title":"Chain mediating effect of insomnia, depression, and anxiety on the relationship between nightmares and cognitive deficits in adolescents","volume":"322","author":"L-G Zhang","year":"2023","journal-title":"J Affect Disord"},{"key":"pone.0330453.ref032","doi-asserted-by":"crossref","first-page":"115279","DOI":"10.1016\/j.psychres.2023.115279","article-title":"Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: A transdiagnostic, multilevel pilot study","volume":"326","author":"JJ Lee","year":"2023","journal-title":"Psychiatry Res"},{"issue":"9","key":"pone.0330453.ref033","article-title":"Validity of handgrip strength for assessing cognition and psychotic symptoms in hospitalized patients with stable schizophrenia","volume":"19","author":"J Pu","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"pone.0330453.ref034","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"ML McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"6","key":"pone.0330453.ref035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.clnu.2023.04.010","article-title":"Sarcopenic obesity by the ESPEN\/EASO criteria for predicting mortality in advanced non-small cell lung cancer","volume":"42","author":"J Zhou","year":"2023","journal-title":"Clin Nutr"},{"key":"pone.0330453.ref036","doi-asserted-by":"crossref","first-page":"155595","DOI":"10.1016\/j.metabol.2023.155595","article-title":"Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile","volume":"145","author":"G Gortan Cappellari","year":"2023","journal-title":"Metabolism"},{"key":"pone.0330453.ref037","doi-asserted-by":"crossref","first-page":"105444","DOI":"10.1016\/j.archger.2024.105444","article-title":"Sarcopenic obesity defined by the ESPEN and EASO consensus statement in older women: Risk of falls and bone mineral density implications","volume":"124","author":"TM Montalv\u00e3o-Sousa","year":"2024","journal-title":"Arch Gerontol Geriatr"},{"key":"pone.0330453.ref038","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clnesp.2024.02.028","article-title":"Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study","volume":"60","author":"S Huang","year":"2024","journal-title":"Clin Nutr ESPEN"},{"issue":"11","key":"pone.0330453.ref039","article-title":"Correlations between nutritional indicators and cognitive function in patients with stable schizophrenia in a hospital setting","volume":"19","author":"B Wang","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"pone.0330453.ref040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40520-019-01435-9","article-title":"Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria","volume":"33","author":"W-Q Xie","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"pone.0330453.ref041","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clnesp.2024.02.028","article-title":"Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study","volume":"60","author":"S Huang","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"pone.0330453.ref042","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.schres.2023.07.010","article-title":"Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments","volume":"258","author":"SR Marder","year":"2023","journal-title":"Schizophr Res"},{"issue":"1","key":"pone.0330453.ref043","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/nbu.12725","article-title":"Sarcopenic obesity and brain health: A critical appraisal of the current evidence","volume":"50","author":"U Booranasuksakul","year":"2025","journal-title":"Nutr Bull"},{"issue":"1","key":"pone.0330453.ref044","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/nyas.15112","article-title":"Pharmacotherapy causing weight gain and metabolic alteration in those with obesity and obesity-related conditions: A review","volume":"1533","author":"CV Anekwe","year":"2024","journal-title":"Ann N Y Acad Sci"},{"key":"pone.0330453.ref045","doi-asserted-by":"crossref","first-page":"108609","DOI":"10.1016\/j.maturitas.2025.108609","article-title":"Systematic review on the relationship between menopausal hormone replacement therapy, sarcopenia, and sarcopenia-related parameters","volume":"199","author":"MF \u00d6sterdahl","year":"2025","journal-title":"Maturitas"},{"key":"pone.0330453.ref046","article-title":"Menopause and Body Composition: A Complex Field","author":"H-K Juppi","year":"2025","journal-title":"Semin Reprod Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T17:24:53Z","timestamp":1755537893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0330453"}},"subtitle":[],"editor":[{"given":"Ioannis","family":"Liampas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0330453","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}